Last reviewed · How we verify
Dust mite extract, Fluticasone, Methacholine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Dust mite extract, Fluticasone, Methacholine (Dust mite extract, Fluticasone, Methacholine) — Novartis.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dust mite extract, Fluticasone, Methacholine TARGET | Dust mite extract, Fluticasone, Methacholine | Novartis | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dust mite extract, Fluticasone, Methacholine CI watch — RSS
- Dust mite extract, Fluticasone, Methacholine CI watch — Atom
- Dust mite extract, Fluticasone, Methacholine CI watch — JSON
- Dust mite extract, Fluticasone, Methacholine alone — RSS
Cite this brief
Drug Landscape (2026). Dust mite extract, Fluticasone, Methacholine — Competitive Intelligence Brief. https://druglandscape.com/ci/dust-mite-extract-fluticasone-methacholine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab